Recent updates on three drug combination regimen for relapsed refractory multiple myeloma.

e20039Background: Two drug regimens comprising proteasome inhibitors, immunomodulatory agents, or a monoclonal antibody are the standard of care for multiple myeloma. However, due to the increased ...